HomeCompareAPELY vs PFE

APELY vs PFE: Dividend Comparison 2026

APELY yields 2.28% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $28.1K in total portfolio value· pulled ahead in Year 9
10 years
APELY
APELY
● Live price
2.28%
Share price
$27.65
Annual div
$0.63
5Y div CAGR
-12.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.5K
Annual income
$66.73
Full APELY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — APELY vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAPELYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, APELY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
APELY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APELY
Annual income on $10K today (after 15% tax)
$193.44/yr
After 10yr DRIP, annual income (after tax)
$56.72/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $22,263.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APELY + PFE for your $10,000?

APELY: 50%PFE: 50%
100% PFE50/50100% APELY
Portfolio after 10yr
$35.5K
Annual income
$13,162.72/yr
Blended yield
37.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

APELY
No analyst data
Altman Z
3.1
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APELY buys
0
PFE buys
0
No recent congressional trades found for APELY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAPELYPFE
Forward yield2.28%6.13%
Annual dividend / share$0.63$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-12.3%13.2%
Portfolio after 10y$21.5K$49.6K
Annual income after 10y$66.73$26,258.71
Total dividends collected$1.2K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: APELY vs PFE ($10,000, DRIP)

YearAPELY PortfolioAPELY Income/yrPFE PortfolioPFE Income/yrGap
1$10,900$199.58$9,153$693.39+$1.7KAPELY
2$11,841$178.30$8,593$849.25+$3.2KAPELY
3$12,828$158.76$8,336$1,066.78+$4.5KAPELY
4$13,867$140.98$8,437$1,384.80+$5.4KAPELY
5$14,963$124.91$9,013$1,875.40+$6.0KAPELY
6$16,121$110.47$10,306$2,680.72+$5.8KAPELY
7$17,347$97.55$12,820$4,101.38+$4.5KAPELY
8$18,647$86.03$17,673$6,826.70+$974.00APELY
9← crossover$20,028$75.80$27,543$12,591.86$7.5KPFE
10$21,497$66.73$49,560$26,258.71$28.1KPFE

APELY vs PFE: Complete Analysis 2026

APELYStock

Alps Alpine Co., Ltd. manufactures and sells electronic components in Japan and internationally. It operates through three segments: Electronic Components, Automotive Infotainment, and Logistics. The Electronic Components segment develops, manufactures, and markets electronic components. The Automotive Infotainment segment develops, manufactures, and markets audio, information, and communication equipment. The Logistics segment offers transportation, storage, and forwarding services. Its products for the consumer, energy, healthcare, industry, and IoT markets include TACT switches, multi-directional operating devices, toroidal coils, aspherical glass lens, PC board mount current sensors, slide potentiometers, encoders, actuators, and reactors, as well as pressure, geomagnetic, force, and humidity sensors; sensor network, environmental sensor, and power conversion modules; compact printers; and remote monitoring system for logistics, worker condition monitoring systems, obstacle detection unit for sidewalks, and ground wire automated tracking and inspection drone systems. The company's products for the automotive market comprises TACT and detector switches, wireless LAN/Bluetooth combination modules, V2X and LTE modules, encoders, and engine start switches; stand position, EGR valve, and current sensors; power windows, electronic parking systems, intelligent control panels, electric shifters, steering wheel modules, sound system speakers, vehicle-approaching alert systems, amplifier for in-vehicle sound systems, displays, and camera/drive recorders; and car navigation systems, premium sound speakers, customized car products, rental car provider solutions, rear seat monitors, and camera systems. It also provides systems development, office, and financing and leasing services. The company was formerly known as Alps Electric Co., Ltd. and changed its name to Alps Alpine Co., Ltd. in January 2019. The company was incorporated in 1948 and is headquartered in Tokyo, Japan.

Full APELY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this APELY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APELY vs SCHDAPELY vs JEPIAPELY vs OAPELY vs KOAPELY vs MAINAPELY vs JNJAPELY vs MRKAPELY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.